R&G PharmaStudies Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 177.33 million compared to CNY 160.93 million a year ago. Revenue was CNY 177.33 million compared to CNY 160.93 million a year ago.

Net income was CNY 23.05 million compared to CNY 28.79 million a year ago. Basic earnings per share from continuing operations was CNY 0.24 compared to CNY 0.3 a year ago. Diluted earnings per share from continuing operations was CNY 0.24 compared to CNY 0.3 a year ago.